Stock Track | Fulgent Genetics Soars 5.46% as UBS Analyst Maintains Buy Rating

Stock Track2025-11-10

Shares of Fulgent Genetics Inc. (FLGT) are soaring in pre-market trading on Monday, with the stock up 5.46% as of 9:39 AM ET. This significant uptick comes on the heels of a positive analyst report from UBS, reaffirming investor confidence in the genetic testing company.

UBS analyst Lu Li has maintained a Buy rating on Fulgent Genetics, setting a price target of $35.00. This vote of confidence from a major financial institution appears to be driving bullish sentiment among investors. Li, who covers the Healthcare sector, sees potential in Fulgent Genetics' business model and growth prospects, contributing to the stock's impressive pre-market rally.

While specific details of the analyst's rationale were not provided, the maintained Buy rating suggests a positive outlook for Fulgent Genetics in the competitive healthcare sector. Investors are likely interpreting this as a signal of the company's strong market position and potential for future growth, driving the stock's upward momentum as the trading week begins.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171959825?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171959825","market":"sg","top_or_hot":-1,"title":"Stock Track | Fulgent Genetics Soars 5.46% as UBS Analyst Maintains Buy Rating","media":"Stock Track","content":"<p>Shares of Fulgent Genetics Inc. (FLGT) are soaring in pre-market trading on Monday, with the stock up 5.46% as of 9:39 AM ET. This significant uptick comes on the heels of a positive analyst report from UBS, reaffirming investor confidence in the genetic testing company.</p>\n\n<p>UBS analyst Lu Li has maintained a Buy rating on Fulgent Genetics, setting a price target of $35.00. This vote of confidence from a major financial institution appears to be driving bullish sentiment among investors. Li, who covers the Healthcare sector, sees potential in Fulgent Genetics' business model and growth prospects, contributing to the stock's impressive pre-market rally.</p>\n\n<p>While specific details of the analyst's rationale were not provided, the maintained Buy rating suggests a positive outlook for Fulgent Genetics in the competitive healthcare sector. Investors are likely interpreting this as a signal of the company's strong market position and potential for future growth, driving the stock's upward momentum as the trading week begins.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Fulgent Genetics Soars 5.46% as UBS Analyst Maintains Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Fulgent Genetics Soars 5.46% as UBS Analyst Maintains Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-10 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Fulgent Genetics Inc. (FLGT) are soaring in pre-market trading on Monday, with the stock up 5.46% as of 9:39 AM ET. This significant uptick comes on the heels of a positive analyst report from UBS, reaffirming investor confidence in the genetic testing company.</p>\n\n<p>UBS analyst Lu Li has maintained a Buy rating on Fulgent Genetics, setting a price target of $35.00. This vote of confidence from a major financial institution appears to be driving bullish sentiment among investors. Li, who covers the Healthcare sector, sees potential in Fulgent Genetics' business model and growth prospects, contributing to the stock's impressive pre-market rally.</p>\n\n<p>While specific details of the analyst's rationale were not provided, the maintained Buy rating suggests a positive outlook for Fulgent Genetics in the competitive healthcare sector. Investors are likely interpreting this as a signal of the company's strong market position and potential for future growth, driving the stock's upward momentum as the trading week begins.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FLGT","symbol_name":"Fulgent Genetics Inc.","start_time":0,"source_url":"","article_id":"1171959825","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171959825","pubTimestamp":1762785951,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Fulgent Genetics Inc. (FLGT) are soaring in pre-market trading on Monday, with the stock up 5.46% as of 9:39 AM ET. This significant uptick comes on the heels of a positive analyst report...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FLGT":"Fulgent Genetics Inc."},"translate_title":"个股追踪|Fulgent Genetics大涨5.46%瑞银分析师维持买入评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FLGT":1},"content_text":"Shares of Fulgent Genetics Inc. (FLGT) are soaring in pre-market trading on Monday, with the stock up 5.46% as of 9:39 AM ET. This significant uptick comes on the heels of a positive analyst report from UBS, reaffirming investor confidence in the genetic testing company.\nUBS analyst Lu Li has maintained a Buy rating on Fulgent Genetics, setting a price target of $35.00. This vote of confidence from a major financial institution appears to be driving bullish sentiment among investors. Li, who covers the Healthcare sector, sees potential in Fulgent Genetics' business model and growth prospects, contributing to the stock's impressive pre-market rally.\nWhile specific details of the analyst's rationale were not provided, the maintained Buy rating suggests a positive outlook for Fulgent Genetics in the competitive healthcare sector. Investors are likely interpreting this as a signal of the company's strong market position and potential for future growth, driving the stock's upward momentum as the trading week begins.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171959825","isCrawlerRequest":true}